438 results on '"Cary, Clint"'
Search Results
2. Critical elements of pediatric testicular germ cell tumors surgery
3. Short and long-term outcomes of arterial and caval replacement during postchemotherapy retroperitoneal lymph node dissection in metastatic testicular cancer
4. Late Relapse of Germ Cell Tumors After Prior Chemotherapy or Surgery-only
5. Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort study
6. Oncological Follow-up Strategies for Testicular Germ Cell Tumours: A Narrative Review
7. Early and Midterm Complications of the Continent Catheterizable Indiana Pouch Urinary Diversion: A 7-year Experience
8. Circulating tumor DNA as a prognostic biomarker to predict retroperitoneal histology in patients undergoing retroperitoneal lymph node dissection.
9. Post chemotherapy retroperitoneal lymph node dissection (PC-RPLND) for metastatic pure seminoma.
10. Stage II embryonal predominant NSGCT: Minimizing treatment burden.
11. Management of relapsed stage I seminomatous germ cell tumor with retroperitoneal or pelvic only relapse.
12. Contemporary short‐term peri‐operative outcomes of open primary retroperitoneal lymph node dissection.
13. Longitudinal evaluation of circulating tumor DNA (ctDNA) as a prognostic biomarker to detect minimal residual disease (MRD) in testicular cancer.
14. Management of relapsed stage I nonseminomatous germ-cell tumor with retroperitoneal only relapse.
15. Post chemotherapy retroperitoneal lymph node dissection (PC-RPLND) for metastatic pure seminoma.
16. Current controversies on the role of lymphadenectomy for testicular cancer for the journal: Urologic Oncology: Seminars and Original Investigations for the special seminars section on the role of lymphadenectomy for urologic cancers
17. Longitudinal Health Related Quality of Life After Open Radical Cystectomy: Comparison of Ileal Conduit, Indiana Pouch, and Orthotopic Neobladder
18. Role of Neoadjuvant Chemotherapy in Squamous Variant Histology in Urothelial Bladder Cancer: Does Presence and Percentage Matter?
19. Xanthogranulomatous pyelonephritis: a comparison of open and minimally-invasive surgical approaches
20. Does larger prostate size provide protection for cancer specific outcomes in localized prostate cancer.
21. Bilateral Leydig Cell Tumors in Klinefelter Patient: A Case Report
22. Improving postoperative quality of care in germ cell tumor patients: Does scheduled alvimopan, acetaminophen, and gabapentin improve short-term clinical outcomes after retroperitoneal lymph node dissection?
23. MP01-14 RETROPERITONEAL NODAL DISTRIBUTION OF METASTATIC SEMINOMA: A CLINICAL MAPPING STUDY
24. MP01-12 ACCURACY OF FDG-PET SCAN IN PRIMARY TESTICULAR SEMINOMA: ANALYSIS FROM SEMS TRIAL
25. RETROPERITONEAL NODAL DISTRIBUTION OF METASTATIC SEMINOMA: A CLINICAL MAPPING STUDY
26. Postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) for seminoma: Limitations of surgical intervention after first-line chemotherapy
27. Complications of Retroperitoneal Lymph Node Dissection
28. Oncologic Outcomes Following Surgical Management of Clinical Stage II Sex Cord Stromal Tumors
29. Can Retroperitoneal Lymph Node Dissection (RPLND) be feasibly performed to prolong survival in Renal Cell Carcinoma (RCC) with limited lymph node involvement? An Analysis of Recurrence Patterns
30. Long-Term Survival of Good-Risk Germ Cell Tumor Patients After Postchemotherapy Retroperitoneal Lymph Node Dissection: A Comparison of BEP × 3 vs. EP × 4 and Treating Institution
31. Barriers to Single-Dose Intravesical Chemotherapy in Non-muscle Invasive Bladder Cancer: Whatʼs the Problem?
32. Disparities in prostate cancer treatment associated with population density of the county of residence
33. A Prospective Program to Reduce the Clinical Incidence of Clostridium Difficile Colitis Infection after Cystectomy
34. Long-term Health-related Quality of Life Outcomes Following Radical Cystectomy
35. Management of Pelvic Metastases in Patients With Testicular Cancer
36. Management of Metastatic Pure Teratoma in Chemotherapy Naive Patients With Testicular Primaries
37. Rare benign and malignant testicular lesions: histopathology and management
38. Definitive surgical therapy for refractory radiation cystitis: Evaluating effectiveness, tolerability, and extent of surgical approach
39. A Randomized Study of Intraoperative Autologous Retropubic Urethral Sling on Urinary Control after Robotic Assisted Radical Prostatectomy
40. Management of Duodenal Involvement During Retroperitoneal Lymph Node Dissection for Germ Cell Tumors
41. Primary Retroperitoneal Lymph Node Dissection for Stage II Seminoma: Is Surgery the New Path Forward?
42. Treatment and Clinical Outcomes of Patients with Teratoma with Somatic-Type Malignant Transformation: An International Collaboration
43. Lessons learned from 40 years of managing chylous ascites following RPLND
44. Understanding the role of salvage lymphadenectomy in node only recurrences after nephrectomy for renal cell carcinoma
45. Postchemotherapy retroperitoneal lymph node dissection in patients presenting with very high HCG levels
46. Advanced nonseminoma
47. Outcomes after primary retroperitoneal lymph node dissection in men with stage 2 non-seminomatous germ cell tumour: A multicenter retrospective cohort study.
48. Utility of circulating tumor DNA (ctDNA) as a predictive biomarker for disease monitoring in patients with non-seminomatous germ-cell tumor (NSGCT).
49. Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer.
50. MP50-07 CONTEMPORARY SHORT-TERM OUTCOMES FOR OPEN VIRGIN RETROPERITONEAL LYMPH NODE DISSECTION
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.